Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92,189,700
-
Total 13F shares
-
69,081,626
-
Share change
-
-1,729,115
-
Total reported value
-
$395,824,161
-
Put/Call ratio
-
55%
-
Price per share
-
$5.73
-
Number of holders
-
143
-
Value change
-
-$5,845,565
-
Number of buys
-
80
-
Number of sells
-
44
Institutional Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q4 2023
As of 31 Dec 2023,
Caribou Biosciences, Inc. - Common Stock (CRBU) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,081,626 shares.
The largest 10 holders included
BlackRock Inc., PFM Health Sciences, LP, Avidity Partners Management LP, STATE STREET CORP, VANGUARD GROUP INC, Point72 Asset Management, L.P., ALKEON CAPITAL MANAGEMENT LLC, Paradigm Biocapital Advisors LP, Elmwood Wealth Management, Inc., and Assenagon Asset Management S.A..
This page lists
143
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.